---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029081"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2026-06-17T20:05:19+00:00"
generated_at: "2026-06-17T20:12:32.161589+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical appoints Chairman Stavros Vizirgianakis as Executive Chairman; grants 450,000 RSUs

## Summary
- Stavros Vizirgianakis appointed Executive Chairman effective June 11, 2026; will lead strategic initiatives and investor engagement.
- Receives 450,000 RSUs: 150,000 vest immediately, 150,000 over 12 months starting year 1, 150,000 over 12 months starting year 2.
- No cash compensation for the role; only expense reimbursement.
- Unvested RSUs fully accelerate upon a Change of Control.
- Vizirgianakis will not be an officer or employee, nor designated as an executive officer.

## SEC filing metadata
- accession: 0001493152-26-029081
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2026-06-17T20:05:19+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/0001493152-26-029081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029081
- JSON: https://secwatch.observer/filing/0001493152-26-029081.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.